A Systematic Review of Measures of Breakthrough Pain and Their Psychometric Properties.

Breakthrough pain COSMIN guidelines measurement properties pain assessment patient-reported outcome measures (PROMs) pediatric

Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
11 2021
Historique:
received: 11 02 2021
revised: 21 04 2021
accepted: 21 04 2021
pubmed: 3 5 2021
medline: 4 11 2021
entrez: 2 5 2021
Statut: ppublish

Résumé

Breakthrough pain (BTP) is common in cancer and other conditions yet there is a lack of validated BTP measurement tools. We aimed to identify all tools assessing or characterising BTP in patients of any age with any condition, and to critically appraise their psychometric properties. The Cochrane Library, PROSPERO, Embase, CINAHL, Medline, PsycINFO, Web of Science, Google Scholar, ProQuest, Evidence Search and OpenGrey were searched to identify all available tools used to assess BTP. A second search identified studies that had evaluated psychometric properties of tools identified in Search 1. Databases were searched from inception to November 2020. Studies were assessed using COSMIN criteria and GRADE guidelines. Search 1 found 51 tools used to assess BTP. Search 2 found six tools that had a development study and/or a study evaluating a tool psychometric property. No tool had more than one study evaluating psychometric properties so a meta-analysis could not be conducted. Studies were of inadequate to very good quality. Only the Breakthrough Pain Assessment Tool (BAT) had sufficient content validity and at least low-quality evidence for sufficient internal consistency. The BAT is recommended to characterise BTP in adults with cancer; its applicability to other conditions is unknown. The remaining tools need further evaluation. Only the Breakthrough Pain Questionnaire for Children was designed for children with cancer, but no psychometric properties were evaluated. There is a need for a tool to assess and characterise BTP in children with non-cancer diagnoses and those who cannot self-report.

Identifiants

pubmed: 33933619
pii: S0885-3924(21)00318-3
doi: 10.1016/j.jpainsymman.2021.04.018
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1041-1064

Informations de copyright

Copyright © 2021 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Christina Liossi (C)

School of Psychology, University of Southampton, Highfield, UK; Great Ormond Street Hospital for Children NHS Foundation Trust, Psychological Medicine, London , UK. Electronic address: c.liossi@soton.ac.uk.

Katie Greenfield (K)

School of Psychology, University of Southampton, Highfield, UK.

Daniel E Schoth (DE)

School of Psychology, University of Southampton, Highfield, UK.

Christine Mott (C)

Hummingbird House Hospice and the Paediatric Palliative Care Service at Queensland Children's Hospital, Australia.

Satbir Jassal (S)

Rainbows Hospice, Lark Rise, Loughborough , UK.

Lorna K Fraser (LK)

Martin House Research Centre, University of York, York , UK.

Dilini Rajapakse (D)

Great Ormond Street Hospital for Children NHS Foundation Trust, The Louis Dundas Centre, London, UK.

Richard F Howard (RF)

Great Ormond Street Hospital for Children NHS Foundation Trust, Department of Anaesthesia and Pain Medicine Level 4, London, UK.

Margaret Johnson (M)

Patient & Public Representative.

Anna-Karenia Anderson (AK)

Royal Marsden Hospital, Sutton, UK.

Emily Harrop (E)

Helen & Douglas House Hospices, Oxford, Oxfordshire, UK; Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Headington, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH